---
title: "Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291868308.md"
description: "Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics (PRCT) with a $25.00 price target. Newitter, a 4-star analyst in the Healthcare sector, has a 7.3% average return. This contrasts with the broader market consensus for PRCT, which stands at Moderate Buy with an average price target of $29.38."
datetime: "2026-07-07T02:45:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291868308.md)
  - [en](https://longbridge.com/en/news/291868308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291868308.md)
---

# Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)

Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics yesterday and set a price target of $25.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Newitter is a 4-star analyst with an average return of 7.3% and a 49.09% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Boston Scientific, Insulet, and Lantheus.

PROCEPT BioRobotics has an analyst consensus of Moderate Buy, with a price target consensus of $29.38.

### Related Stocks

- [PRCT.US](https://longbridge.com/en/quote/PRCT.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [LNTH.US](https://longbridge.com/en/quote/LNTH.US.md)

## Related News & Research

- [04:49 ETPROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT](https://longbridge.com/en/news/293903794.md)
- [PROCEPT BioRobotics Shareholders Back Board, Pay and Auditor](https://longbridge.com/en/news/289380430.md)
- [Sensorion SAS (RFM) Receives a New Rating from Chardan Capital](https://longbridge.com/en/news/293386223.md)
- [Elevance Health, Inc. $ELV Shares Acquired by Cetera Investment Advisers](https://longbridge.com/en/news/293896171.md)
- [Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?](https://longbridge.com/en/news/293625486.md)